{
  "$schema": "folio-library-entry/v1",
  "id": "10665-59577",
  "blocks": [
    {
      "id": "library/10665-59577/blocks/prose-page-001",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 1",
      "pageStart": 1,
      "pageEnd": 1,
      "target": "../sections/page-001.md",
      "narrative": null,
      "content": "‘, WORLD HEALTH ORGANIZATION\nORGANISATION MONDIALE DE LA SANTE\n\nAeguired rene ur he fr eee.\nAELV- i\n\nwHo /CDS/AIDS/86.14°\n\nORIGINAL: ENGLISH\n\nAn hel poe\nif ¢. ae al e _ f\nprbresh ten ated tou 2?\n\nbsg!\n\nGUIDELINES FOR THE PREVENTION AND CONTROL OF INFECTION\n\nWITH LAV/RTLV IIIT\n\nMay 1986",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "The cover page of WHO's May 1986 guidelines for the prevention and control of infection with LAV/HTLV-III (document WHO/CDS/AIDS/86.1), with handwritten annotations rendered as garbled OCR.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-59577/blocks/prose-page-002",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 2",
      "pageStart": 2,
      "pageEnd": 2,
      "target": "../sections/page-002.md",
      "narrative": null,
      "content": "_(no text on this page)_",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A blank page with no extracted text.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-59577/blocks/prose-page-003",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 3",
      "pageStart": 3,
      "pageEnd": 3,
      "target": "../sections/page-003.md",
      "narrative": null,
      "content": "GUIDELINES FOR THE PREVENTION AND CONTROL OF INFECTION\nWITH LAV/HTLV-IIY\n\nWHO has committed itself to the preparation and distribution of guidelines\nfor the prevention and control of infection with LAV/HTLV-III.\nare broad in nature and therefore suitable for international application.\nThey are based on the experience of many member countries and advice from the\n\nWHO AIDS and Biosafety Collaborating Centres.\n\nThe guidelines are not complete at this time as some are currently under\ndevelopment, These are indicated by * on the list of contents, The complete\n\nguidelines will be made available as s",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "The introductory page and first part of the contents of the 1986 LAV/HTLV-III guidelines, explaining that they are broad, based on Member State experience and WHO collaborating centres, and still partly under development. The contents list sections on the virus, transmission, clinical features, laboratory detection, case definitions and precautions for various health and non-health workers.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-59577/blocks/prose-page-004",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 4",
      "pageStart": 4,
      "pageEnd": 4,
      "target": "../sections/page-004.md",
      "narrative": null,
      "content": "WHO/CDS/AIDS/86.1\npage 2\n\n5. Guidance for health professionals\n\n5.1* Screening\n5.2* Diagnostic testing\n5.3% Counselling of seropositive persone\n\n6. Guidance for high risk groups and the general population\n\n6.1* Prevention of sexual transmission\n6,2* Pravention of parenteral transmission\n6.3* Education and foster care\n\n7, Disinfection and sterilization\n\n1 Commonly available disinfectants\n\n-2 Sterilization\n\n.3 Processing needles and syringes\n\n.4* Care of eye examination instruments and contact lenses,",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Continues the contents of the 1986 LAV/HTLV-III guidelines, listing planned sections on guidance for health professionals, high-risk groups and the general population, and disinfection and sterilization.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-59577/blocks/prose-page-005",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 5",
      "pageStart": 5,
      "pageEnd": 5,
      "target": "../sections/page-005.md",
      "narrative": null,
      "content": "WHO/CDS/ATDS/86.1\npage 3\n\nGUIDELINES FOR THE PREVENTION AND CONTROL OF INFECTION\nWITH LAV/HTLV-II1\n\n1. Introduction\n\n-An important component of the WHO AIDS Control Programme (ACP) is\n\npreparation and distribution of guidelines, manuals and educational materials\n\non prevention and control of LAV/HTLV-III infections for professional\n\npersonnel, for groups at risk and for the general public. The ultimate goal\n\nof the ACP guidelines is prevention of LAV/HTLV-III transmission, using\n\nstrategies firmly anchored in fundamental public health concepts and utilizing\n\nthe best available knowledge on the",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Introduces the guidelines as part of the WHO AIDS Control Programme, aimed at public health authorities and health professionals who must adapt them to local settings, and notes they will be revised as knowledge grows. It describes the virus and states that only blood and semen have been implicated in transmission, through sexual, parenteral and perinatal routes.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-59577/blocks/prose-page-006",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 6",
      "pageStart": 6,
      "pageEnd": 6,
      "target": "../sections/page-006.md",
      "narrative": null,
      "content": "WHO/CDS/AIDS/86.1\npage 4\n\nWorldwide, the most important wode of transmission is sexual,\nLAV/RTLV-ILL can spread bi-directionally between heterosexual or homosexual\npartners, Transmission of LAV/ATLV-III through semen donation has also been\ndocumented, Parenteral LAV/HTLV-IIL transmission can occur through\ntransfusion of whole blood, blood cells, platelets, or factors VIII or IX\nderived from contaminated human plasma, In addition, the accidental or\nintentional sharing or reuse of contamined (unsterilized) needles, syringes,\nscalpels, razors, or other skin or mucous membrane-piereing inetruments",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that sexual transmission is the most important route worldwide, alongside transmission through blood, blood products, shared needles and from mother to child, and that the virus is not spread by casual contact, insects, food or water. It begins describing clinical features and laboratory methods for detecting infection.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-59577/blocks/prose-page-007",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 7",
      "pageStart": 7,
      "pageEnd": 7,
      "target": "../sections/page-007.md",
      "narrative": null,
      "content": "WHO/CDS/AIDS/86.1\npage 5\n\ninfection in the community, assessing the likelihood that an individual has\nbeen exposed to LAV/HILV-III, and evaluating various methods of preventing or\ntreating the disease,\n\nAt present, the only practical approach for routine or large-scale testing\nis detection of antibody to LAV/HTLV-III and the enzyme-linked immunosorbent\nassay (ELISA) is the antibody detection method most frequently used, ELISA\ntest systems are highly sensitive (98%); however, not all reactive sera are\nindicative of LAV/HTLV-III infections because of non-specific reactions, In\ngeneral, the perce",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes antibody testing by ELISA, which is highly sensitive but gives some false positives, so repeatedly reactive samples should be confirmed with another test. It then introduces the WHO/CDC case definition of AIDS based on opportunistic diseases indicating cellular immunodeficiency.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-59577/blocks/prose-page-008",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 8",
      "pageStart": 8,
      "pageEnd": 8,
      "target": "../sections/page-008.md",
      "narrative": null,
      "content": "WHO/CDS/AIDS/86,1\npage 6\n\n- absence of all known underlying causes of cellular immunodeficiency\nCother than LAV/HTLV-III infection) and absence of a11 other causes of\n\nreduced resistance reported to be associated with at least one of those\nopportunistic diseases.\n\nDespite having the above, patients are excluded as AIDS cases if they have\nnegative result(s) on testing for serum antibody to LAV/HTLV-IIT, do not have\na positive culture for LAV/HTLV-I11, and have both a normal or high number of\nT-helper (OKT4 or LEU3) lymphocytes and a normal or high ratio of T-helper to\nT-suppressors (OKT8 or LEU",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Completes the WHO/CDC AIDS case definition, including exclusion criteria based on negative tests and normal T-helper counts. It then gives the clinical case definitions for adults and begins the definition for paediatric AIDS.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-59577/blocks/prose-page-009",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 9",
      "pageStart": 9,
      "pageEnd": 9,
      "target": "../sections/page-009.md",
      "narrative": null,
      "content": "WHO/CDS /AIDS/86.1\npage 7\n\nMajor signs\nbad weight loss or abnormally slow growth;\n- chronic diarrhoea > 1 month;\n\n- prolonged fever 5 1 month,\n\nMinor signs\n- generalized lymphadenopathy;\n\n- oro-pharyngeal candidiasis;\n\n~ repeated common infections (otitis, pharyngitis, etc.)\n- persistent cough;\n\n- generalized dermatitis;\n\n- confirmed maternal LAV/HTLV-LII infection\n\nThese clinical case definitions are believed to be sensitive but have not\nyet been formally evaluated. There may be differences in clinical features\n\namong different countries, Therefore, there ig an urgent need to carefully\nevalua",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Lists major and minor signs for the clinical definition of paediatric AIDS and calls for evaluating clinical definitions in different settings. It opens the recommendations for health care workers, stressing avoidance of exposure to patients' blood and keeping workers with weeping lesions from direct patient contact.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-59577/blocks/prose-page-010",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 10",
      "pageStart": 10,
      "pageEnd": 10,
      "target": "../sections/page-010.md",
      "narrative": null,
      "content": "WHO/CDS/ATDS /86.1\npage &\n\nrequires tigorous sterilization of reusable equipment such as needles,\nsyringes and skin~plercing instruments.\n\n2.1 Precautions for HCWs\n\nThese precautions represent prudent practices that apply to preventing\ntransmission of all bloodborne infections and should be used routinely.\n\n2.4.1. Sharp items (needles, scalpel blades, and other instruments) should\nbe considered as potentially infective, should be handled with extraordinary\ncare to prevent accidental injuries, and should be placed into\npuncture-resistant containers located as close as practical to the area in\nw",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Sets out precautions for health care workers against bloodborne infections, including careful handling and disposal of sharps without recapping, safe destruction of disposable needles and syringes, and use of gloves, gowns and masks where appropriate. It also covers handling of specimens, waste and reusable instruments, including those with lenses.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-59577/blocks/prose-page-011",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 11",
      "pageStart": 11,
      "pageEnd": 11,
      "target": "../sections/page-011.md",
      "narrative": null,
      "content": "WHO/CDS/ATDS/86.1\npage 9\n\n2.1.6, Disposable needles and syringes are preferred. Only needle-locking\nsyringes or one-piece needle-syringe units should be used to aspirate fluids\n\nfrom patients, so that collected fluid can be safely discharged through the\nneedle, if desired, If reusable syringes are employed, they must be\n\nsterilized before reuse (see section 7.3) and special care must be taken in\nhandling to avoid injuries,\n\n2.1.7. Precautious such as single-room isolation are not generally indicated\nfor LAV/RTLV-LII infected patients. However, to the extent possible, a\nprivate room may be indi",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Recommends disposable or safely sterilized needles and syringes, explains that single-room isolation is not usually needed except in specific circumstances, and advises on resuscitation equipment. It also covers precautions for home care and pre-hospital emergency care providers.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-59577/blocks/prose-page-012",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 12",
      "pageStart": 12,
      "pageEnd": 12,
      "target": "../sections/page-012.md",
      "narrative": null,
      "content": "WHO/CDS/AIDS/86,1\npage 10\n\nblood or other body fluids should be used once and disposed or be thoroughly\ncleaned and disinfected (see section 7,1).\n\n2.4 Management of parenteral and mucous membrane exposure\n\nlt a HCW has a parenteral (e.g,, needlestick or cut) or mucous membrane\n(e.g., splash to eye or mouth) exposure to blood or other body fluids, the\nsource patient should be assessed clinically and epidemiologically to\ndetermine the likelihood of LAV/HTLV-1II infection. In some situations\nserologic testing of the source patient may be considered. If the source\npatient has evidence of LAV/HTLV",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes managing needlestick or mucous membrane exposures, including assessing the source patient and testing and following up exposed workers for up to a year. It then sets out laboratory precautions, such as using biological safety cabinets for procedures likely to create aerosols.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-59577/blocks/prose-page-013",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 13",
      "pageStart": 13,
      "pageEnd": 13,
      "target": "../sections/page-013.md",
      "narrative": null,
      "content": "WHO/CDS/ATDS/86.1\npage 11\n\neges. Fluorescent activated cell sorters generate droplets that could\npotentially result in infectious aerosols, Translucent plastic shielding\nbetween the droplet-collecting area and the equipment operator should be used\nto reduce the presently uncertain magnitude of this risk, Primary containment\ndevices are also used in handling materials that might contain concentrated\ninfectious agents or organisms in greater quantities than expected in clinical\nspecimens.\n\n2.5.7 Laboratory work surfaces should be decontaminated with a\ndisinfectant, such as sodium hypochlorite so",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Continues laboratory precautions, including shielding cell sorters, decontaminating surfaces and materials, hand washing and banning eating or smoking in the laboratory, and gives precautions for animal work. Sections on dental care, necropsies and morticians are marked as still in preparation.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-59577/blocks/prose-page-014",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 14",
      "pageStart": 14,
      "pageEnd": 14,
      "target": "../sections/page-014.md",
      "narrative": null,
      "content": "WHO/CDS/AIDS/86,1\npage 12\n\n2.9 Eye examiners*\n\n3. Considerations relevant to non health cate workers\n\n3.1 Personal service workers\n\nPersonal service workers are defined as individuals whose occupations\ninvolve close personal contact with clients (e.g. hairdressers, barbers,\nmanicurists, pedicurists, massage therapists). Personal service workers whose\nservices (tattoolng, ear piercing, acupuncture, etc.) require needles or other\ninstruments that penetrate the skin should follow precautions indicated for\nhealth care workers, Particular care must be taken to ensure that all\nskin-piercing instrume",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Covers non-health care workers, advising that personal service workers who pierce the skin follow health worker precautions and properly disinfect instruments, though no transmission has been documented in such settings. It states that food service workers with LAV/HTLV-III need not be restricted from work unless they have other illnesses.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-59577/blocks/prose-page-015",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 15",
      "pageStart": 15,
      "pageEnd": 15,
      "target": "../sections/page-015.md",
      "narrative": null,
      "content": "wHo/cps/AIDS/86.1\npage 13\n\n3,3 Workers sharing same work environment\n\nNo known risk of transmission to coworkers, clients of consumers exists\nfrom LAV/HTLV-III infected workers in other settings (e.g. offices, schools,\nfactories, construction sites), Workers known to be infected with\nLAV/HTLV-III should not be restricted from work solely based on this finding.\nMoreover, they should not be restricted from using telephones, office\nequipment, toilets, showers, eating facilities and water fountains. In\ngeneral, equipment contaminated with blood or other body fluids of any worker\nshould be cleaned",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "States that infected workers in offices, schools and other settings pose no known risk and should not be restricted, with routine cleaning of contaminated equipment. It notes some sections are pending and begins the section on disinfection, describing sodium hypochlorite and differences in strength of household bleach products between countries.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-59577/blocks/prose-page-016",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 16",
      "pageStart": 16,
      "pageEnd": 16,
      "target": "../sections/page-016.md",
      "narrative": null,
      "content": "WHO/CDS/AIDS/86.1\npage 14\n\n4 10 to 30 minute contact time is required depending upon level of\ncontamination of material to be disinfected.\n\n7.1.2, Formaldehyde as Formalin: 50 g/litre (5%). 10-30 minute contact time.\n\n7.143, Ethanol; 700 g/litre (702). 10-30 minute contact time,\n7.1.4, Glutaraldehyde: 20 g/litve (24). 10-30 minute contact time.\n7.2 Sterilization\n\n7.2.1 Ideally, all reusable patient care equipment and instruments entering\nthe blood stream or tissue should be sterilized by steam under pressure\n(autoclaving), Autoclaves should be operated at 121°C (250°F) for a\n\nminimum exposure",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Gives contact times for disinfectants such as formalin, ethanol and glutaraldehyde, and describes sterilization by autoclaving or boiling and high-level disinfection of heat-sensitive equipment. It sets out a step-by-step method for processing reusable needles and syringes.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-59577/blocks/prose-page-017",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 17",
      "pageStart": 17,
      "pageEnd": 17,
      "target": "../sections/page-017.md",
      "narrative": null,
      "content": "WHO/CDS/AIDS/86.1\npage 15\n\n~ Disinfect or sterilize syringe and needle by autoclaving (steam\nsterilizer) or boiling prior to reuse,\n\n7.4 Care of eye examination instruments and contact lenses*",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Ends the processing steps with sterilizing needles and syringes before reuse, and lists the care of eye instruments and contact lenses as a section still in preparation.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-59577/blocks/prose-page-018",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 18",
      "pageStart": 18,
      "pageEnd": 18,
      "target": "../sections/page-018.md",
      "narrative": null,
      "content": "_(no text on this page)_",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A blank page with no extracted text.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-59577/blocks/prose-page-019",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 19",
      "pageStart": 19,
      "pageEnd": 19,
      "target": "../sections/page-019.md",
      "narrative": null,
      "content": "WHO/CDS/ATDS/86.1\nAnnex 1\npage 1\n\nProvisional\n\nWORLD HEALTH ORGANIZATION 2 April 1986\nREPORTING FORM ON ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS)\n\nReporting Officer: Name (code) of country:\n\nUnit/department: Reporting period\n\n1: 1.\nDate of report: Monthi: Quarter!,:\n\nLA. Number of cases meeting CDC/WHO case definition”\n\n1B. Number of cases meeting clinical case definition? but not\nCDC/WHO case definition\n\nOf clinical cases, how many were serotested?\n\nOf clinical cases serotested, how many were positive by\ninitial test (ELISA, other)?\n\nOf clinical cases positive by initial test, how many\nwere c",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Presents the first page of WHO's provisional 1986 AIDS reporting form, asking countries to report cases meeting the WHO/CDC or clinical definitions and how many clinical cases were serotested and confirmed. It also asks for cases by age, sex and disease category, such as opportunistic infection or Kaposi's sarcoma, with footnotes on reporting periods and totals.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-59577/blocks/prose-page-020",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 20",
      "pageStart": 20,
      "pageEnd": 20,
      "target": "../sections/page-020.md",
      "narrative": null,
      "content": "WHO/CDS/AIDS/86.1\nAnnex 1\npage 2\n5. Risk factor\n5A.\n\n1\n\nAdult cases (15 years old or older)\n\nRisk factor Male Female |Unknown | Total\n\nHomosexual male\n\nBisexual male\n\nIntravenous drug user\n\nHaemophiliac\n\nHeterosexual contact?\n\nBlood transfusion?\n\nOther\n\nNo risk factor?\n\nUnknown®\n\nTotal number of adult cases\n\n5B. Paediatric cases ( “¢ 15 years old)\n\nRisk factor Male Female {Unknown | Total\n\nParent with LAV/HTLV-III antibody/ARC/AIDS\n\nParent in high risk group’\n\nBlood transfusion3\n\nHaemophiliac\n\nOtherS\n\nNo risk factor?\n\nUnknown®\n\nTotal number of paediatric cases\n\n6, Of total number of cases repo",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Continues the AIDS reporting form, asking for adult and paediatric cases by risk factor and sex and for numbers of resident, imported and visiting cases. Footnotes explain the hierarchical risk categories and how totals should match.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    }
  ]
}
